Navigation Links
Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program
Date:8/26/2010

SUNRISE, Fla., Aug. 26 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico. In March, Bioheart entered into an agreement to establish a Center of Excellence for the introduction of its therapies. Through the program with Bioheart, Regenerative Medicine Institute provides therapies for congestive heart failure (CHF) and peripheral arterial disease (PAD) patients at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital.

The therapy involved the use of stem cells derived from the patient's own fat (adipose tissue) obtained using liposuction. Stem cells were separated from the adipose tissue utilizing the fully-automated TGI Cell Isolation System. The separation process takes about an hour. No tissue pre-processing is required with this system. The recovered stem cells were injected into the patients' hearts with Bioheart's MyoCath® needle injection catheter.

Dr. Juan J. Parcero, the treating Interventional Cardiologist and head of the cardiac program at the Hospital Angeles commented on Bioheart's program, "The ability to offer cutting edge treatments and regenerative medicine has provided new hope to these patients. We are very pleased with the positive outcomes seen in the patients treated so far." Dr. Parcero has led the efforts with this new program with expert team members Drs. Oscar Mendoza and Luis Ruvalcaba, Echo cardiologists, Dr. Silvia Gonzalez, Plastic Surgeon, Dr. Nelson Varas, Anesthesiologist Cardiologist and Dr. Jesus Perez, Hospitalist.

To date, four patients have been treated utilizing the TGI Cell Isolation Syst
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Bioheart, Inc. Announces Additional Funding Support
2. United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients
3. Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
4. Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd
5. Bioheart Makes Breakthrough in Critical Limb Ischemia Therapy with Stem Cells Obtained from Fat Tissue
6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. Pharmos Corporation Reports 2008 Second Quarter Results
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... The latest addition to ... which prints and verifies labels automatically. Companies in the pharmaceutical and healthcare industry can ... up to 500 per minute. The Label Serialization Station can be fully integrated into ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... 18 months ago. Conventional treatment and therapy were not working so Zach decided ... 2015. Dr. McKenna treated Zack with precisely guided injections of bone marrow aspirate ...
(Date:9/3/2015)... , Sept. 3, 2015  Guardant Health®, ... five abstracts highlighting the performance and clinical utility ... accepted for oral and poster presentations at the ... 16th World Conference on Lung Cancer. These abstracts ... University of California, Davis; the University of Chicago; ...
(Date:9/3/2015)... AUSTIN, Texas , Sept. 3, 2015  Vermillion, ... focused on gynecologic disease, today announced that Herbert ... owned subsidiary, ASPiRA LABS, is the recipient of the ... Oncology and Biomarkers (ISOBM) for outstanding contributions to the ... receive the award on October 5 th in ...
Breaking Biology Technology:Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 2UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2
... Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader in the field ... its financial results for the first,six months of 2007 ... European,Time (CET). To discuss these results, the Company ... Dial In: +31-800-949-4517 (toll free); US Dial In:,+1-866-291-4166 (toll ...
... symbol: SBS, - Canadian Biotechnology Company confirms commercial ... AI Milano variant and clarifies status of native ... - SemBioSys Genetics Inc.,(TSX:SBS), a biotechnology company developing ... diseases, today updated a release,issued on July 12, ...
... ROG.VX; RO.S),a world-leading healthcare provider of pharmaceuticals and diagnostics,announced ... all of the,outstanding common shares of Ventana Medical Systems, ... City time on Thursday, September 20, 2007. The,tender offer ... York City,time, on August 23, 2007. All other terms ...
Cached Biology Technology:SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/24/2015)... 2015 The consulting company Frost & ... manufacturer DERMALOG and its customized solutions and products for ... of the Year Award". DERMALOG is particularly successful with a ... -Cross reference: Picture is available at AP Images ... On Thursday evening, in South Africa,s ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... happens just about everywhere, and every day, with learning ... smoothly functioning organizations, better productivity and potentially more profit. ... or nurses can connect more with patients. So, doing ... and it has been a major topic of research ...
... cells spring into action to begin repairing muscle damaged in ... Medicine found that a protein naturally produced in the body ... Giving the right dose of this protein named secreted frizzled ... prevent heart failure and reduce collagen layering that can form ...
... CHAMPAIGN, Ill. In September, 2007, the Anaktuvuk River Fire ... North Slope, doubling the area burned in that region since ... of sediment cores from the burned area revealed that this ... at least 5,000 years. Models built on 60 years of ...
Cached Biology News:Coaching with compassion can 'light up' human thoughts 2Coaching with compassion can 'light up' human thoughts 3Coaching with compassion can 'light up' human thoughts 4A stem cell secreted protein can be given to improve heart function after experimental heart attack 2As Arctic temperatures rise, tundra fires increase, researchers find 2
Provides continuous mixing action. For use with tubes, vials, and other containers...
... and Gel Band Purification Kit, 100. For the ... DNA fragments (0.1-10 kb) from solution and from ... fragments from solution in as little as 5 ... 15 min.Prepacked glass fiber matrix columns provide consistent ...
Bethyl Laboratories Epitope Retrieval Buffer-Reduced pH will unmask antigenic sites from formaldehyde fixation and allow for subsequent immunostaining. Shelf-Life: 1 year from date of receipt...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: